Literature DB >> 20869353

Distribution of SV2C mRNA and protein expression in the mouse brain with a particular emphasis on the basal ganglia system.

D Dardou1, D Dassesse, L Cuvelier, T Deprez, M De Ryck, S N Schiffmann.   

Abstract

Synaptic vesicle 2 proteins (SV2), SV2A, SV2B and SV2C, are integral proteins localized on the surface of synaptic vesicles in all neurons. SV2 proteins appear to play an important, but not yet fully understood role in synaptic vesicle exocytosis and neurotransmitter release. Moreover, SV2 seems to be the receptor of the botulinum neurotoxin A. In the present study, using single and double-labeling fluorescent immunohistochemistry and in situ hybridization we have identified the brain pattern of SV2C mRNA and protein expression in mice. Our results indicated that SV2C protein was expressed in a small subset of brain regions including the olfactory bulb, olfactory tubercle, nucleus accumbens, caudate-putamen, ventral pallidum, globus pallidus, substantia nigra and the ventral tegmental area. These results were confirmed by means of in situ hybridization, except for the globus pallidus and the substantia nigra pars reticulata, in which no labeling was found, suggesting that SV2C-positive fibers in these areas are terminals of striatal projecting neurons. In the striatum, we found that, in addition to its presence in the projection neurons, SV2C was densely expressed in a fraction (around 45%) of cholinergic interneurons. In addition, our data also showed that SV2C was densely expressed in most dopaminergic neurons in the substantia nigra pars compacta and the ventral tegmental area (more than 70% of the dopaminergic neurons analyzed were SV2C-positive). Altogether, our results suggest that SV2C may contribute to the regulation of neurotransmitter release and synaptic transmission in the basal ganglia including cholinergic striatal interneurons and nigro-striatal/mesolimbic dopamine neurons.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20869353     DOI: 10.1016/j.brainres.2010.09.063

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  19 in total

1.  Genotypic variation in the SV2C gene impacts response to atypical antipsychotics the CATIE study.

Authors:  Timothy L Ramsey; Qian Liu; Bill W Massey; Mark D Brennan
Journal:  Schizophr Res       Date:  2013-07-23       Impact factor: 4.939

2.  Immunochemical analysis of the expression of SV2C in mouse, macaque and human brain.

Authors:  Amy R Dunn; Carlie A Hoffman; Kristen A Stout; Minagi Ozawa; Rohan K Dhamsania; Gary W Miller
Journal:  Brain Res       Date:  2017-12-21       Impact factor: 3.252

Review 3.  Genetics and Treatment Response in Parkinson's Disease: An Update on Pharmacogenetic Studies.

Authors:  Cristina Politi; Cinzia Ciccacci; Giuseppe Novelli; Paola Borgiani
Journal:  Neuromolecular Med       Date:  2018-01-05       Impact factor: 3.843

4.  Mutant Huntingtin Causes a Selective Decrease in the Expression of Synaptic Vesicle Protein 2C.

Authors:  Chaohua Peng; Gaochun Zhu; Xiangqian Liu; He Li
Journal:  Neurosci Bull       Date:  2018-04-30       Impact factor: 5.203

5.  Identification of Risk Loci for Parkinson Disease in Asians and Comparison of Risk Between Asians and Europeans: A Genome-Wide Association Study.

Authors:  Jia Nee Foo; Elaine Guo Yan Chew; Sun Ju Chung; Rong Peng; Cornelis Blauwendraat; Mike A Nalls; Kin Y Mok; Wataru Satake; Tatsushi Toda; Yinxia Chao; Louis C S Tan; Moses Tandiono; Michelle M Lian; Ebonne Y Ng; Kumar-M Prakash; Wing-Lok Au; Wee-Yang Meah; Shi Qi Mok; Azlina Ahmad Annuar; Anne Y Y Chan; Ling Chen; Yongping Chen; Beom S Jeon; Lulu Jiang; Jia Lun Lim; Juei-Jueng Lin; Chunfeng Liu; Chengjie Mao; Vincent Mok; Zhong Pei; Hui-Fang Shang; Chang-He Shi; Kyuyoung Song; Ai Huey Tan; Yih-Ru Wu; Yu-Ming Xu; Renshi Xu; Yaping Yan; Jing Yang; BaoRong Zhang; Woon-Puay Koh; Shen-Yang Lim; Chiea Chuen Khor; Jianjun Liu; Eng-King Tan
Journal:  JAMA Neurol       Date:  2020-06-01       Impact factor: 18.302

6.  Commentary: Synaptic vesicle glycoprotein 2C (SV2C) modulates dopamine release and is disrupted in Parkinson disease.

Authors:  Sachchida Nand Rai; Hareram Birla; Walia Zahra; Saumitra Sen Singh; Surya Pratap Singh
Journal:  Front Synaptic Neurosci       Date:  2018-01-04

Review 7.  Puzzling Out Synaptic Vesicle 2 Family Members Functions.

Authors:  Odile Bartholome; Priscilla Van den Ackerveken; Judit Sánchez Gil; Orianne de la Brassinne Bonardeaux; Pierre Leprince; Rachelle Franzen; Bernard Rogister
Journal:  Front Mol Neurosci       Date:  2017-05-22       Impact factor: 5.639

8.  A genetic basis for the variable effect of smoking/nicotine on Parkinson's disease.

Authors:  E M Hill-Burns; N Singh; P Ganguly; T H Hamza; J Montimurro; D M Kay; D Yearout; P Sheehan; K Frodey; J A McLear; M B Feany; S D Hanes; W J Wolfgang; C P Zabetian; S A Factor; H Payami
Journal:  Pharmacogenomics J       Date:  2012-10-02       Impact factor: 3.550

9.  Expression of SV2 isoforms during rodent brain development.

Authors:  Julie Crèvecœur; Patrik Foerch; Melissa Doupagne; Caroline Thielen; Catherine Vandenplas; Gustave Moonen; Manuel Deprez; Bernard Rogister
Journal:  BMC Neurosci       Date:  2013-08-09       Impact factor: 3.288

Review 10.  Synaptic Vesicle Glycoprotein 2A Ligands in the Treatment of Epilepsy and Beyond.

Authors:  Wolfgang Löscher; Michel Gillard; Zara A Sands; Rafal M Kaminski; Henrik Klitgaard
Journal:  CNS Drugs       Date:  2016-11       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.